GO:1904357 negative regulation of telomere maintenance via telomere lengthening: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904357 describes any process that stops, prevents, or reduces the frequency, rate, or extent of telomere maintenance via telomere lengthening, a critical brake on unlimited proliferative capacity.
• Telomere lengthening occurs mainly through telomerase (TERT) or alternative lengthening of telomeres (ALT); negative regulation of these pathways is essential to limit cancer risk.
• Key negative regulators include TERT repressors, shelterin components, and factors that resolve telomeric R-loops and G-quadruplexes, such as DHX36 and RBM14.
• ALT is a telomerase-independent lengthening mechanism that can be negatively regulated by DNA polymerase lambda and SLX4IP, among others.
• Dysregulation of negative regulation is linked to cancer, neuromuscular disorders, and pancreatic neuroendocrine tumors.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable precise dissection of these regulatory mechanisms.
Description
Telomeres are nucleoprotein structures that protect chromosome ends and limit replicative lifespan. Telomere maintenance via telomere lengthening counteracts progressive shortening and is executed primarily by telomerase or by the alternative lengthening of telomeres (ALT) pathway. The Gene Ontology term GO:1904357, negative regulation of telomere maintenance via telomere lengthening, captures the cellular processes that restrain these lengthening activities, thereby preventing unchecked telomere extension. This regulation is fundamental because excessive telomere elongation can promote genomic instability and tumorigenesis, while insufficient restraint may contribute to stem cell exhaustion and degenerative phenotypes. Research into GO:1904357 has revealed a diverse set of molecular players. For example, TERT, the catalytic subunit of telomerase, is subject to multiple layers of negative regulation that integrate genomic instability and immune modulation. In ALT-positive cancers, factors such as SLX4IP and DNA polymerase lambda influence telomeric localization and recombination, thereby modulating lengthening. Additionally, RNA-binding proteins like RBM14 and the G-quadruplex resolvase DHX36 regulate telomere integrity at the interface of TERRA and telomeric R-loops, providing additional brakes on telomere lengthening. Understanding GO:1904357 is therefore essential for cancer biology, aging research, and the development of targeted therapies. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of the mechanisms, genes, diseases, and experimental models associated with this term.
negative regulation of telomere maintenance via telomere lengthening At A Glance
| GO ID | GO:1904357 |
|---|---|
| GO term | negative regulation of telomere maintenance via telomere lengthening |
| Ontology | biological_process |
| Synonym | down regulation of telomere maintenance via telomere lengthening; down-regulation of telomere maintenance via telomere lengthening; downregulation of telomere maintenance via telomere lengthening; inhibition of telomere maintenance via telomere lengthening |
| Major function | Restrains telomere elongation by telomerase or ALT, preventing excessive telomere extension and maintaining genomic stability. |
| Related processes | Telomere maintenance, telomere lengthening, telomerase activity, alternative lengthening of telomeres (ALT). |
| Key regulators | TERT, SLX4IP, DNA polymerase lambda, RBM14, DHX36. |
| Disease relevance | Cancer, neuromuscular disorders, pancreatic neuroendocrine tumors. |
What Is GO:1904357?
GO:1904357, negative regulation of telomere maintenance via telomere lengthening, is defined as any process that stops, prevents, or reduces the frequency, rate, or extent of telomere maintenance via telomere lengthening. In other words, it encompasses all cellular mechanisms that put a brake on the extension of telomeres, whether through telomerase or alternative lengthening pathways.
Why Is negative regulation of telomere maintenance via telomere lengthening Important in Cell Biology?
GO:1904357 is critically important because it serves as a safeguard against unlimited telomere elongation, a hallmark of cancer and a determinant of cellular lifespan. Dysregulation of this negative regulation can lead to telomere dysfunction, genomic instability, and altered immune responses, as highlighted by TERT's role in integrating genomic instability and immune modulation. Moreover, understanding this process offers therapeutic opportunities: inhibiting negative regulators could enhance telomere maintenance in degenerative diseases, while activating them could limit cancer cell proliferation.
• Prevents excessive telomere elongation that could drive tumorigenesis.
• Modulates replicative lifespan and stem cell function.
• Influences genomic instability and immune surveillance in cancer.
• Plays a role in neuromuscular disorders through satellite cell dysfunction.
• Affects prognosis in pancreatic neuroendocrine tumors via fusion genes.
• Regulates ALT pathway activity in sarcomas and prostate cancer.
• Involves RNA-binding proteins and G-quadruplex resolvases in telomere integrity.
• Provides targets for CRISPR-based functional screens.
• Helps explain resistance to telomerase inhibitors.
• Links telomere biology to aging and age-related diseases.
What Happens During negative regulation of telomere maintenance via telomere lengthening?
Inhibition of Telomerase Activity
In simple terms: This step blocks the enzyme telomerase from adding DNA repeats to chromosome ends.
Negative regulation of telomere maintenance via telomere lengthening often begins with the suppression of telomerase, the enzyme responsible for adding TTAGGG repeats. TERT, the catalytic subunit, is a key target; its expression and activity are downregulated by various factors, including transcriptional repressors and post-translational modifications. This inhibition prevents telomere elongation and limits cellular proliferative capacity.
Suppression of Alternative Lengthening of Telomeres (ALT)
In simple terms: This step stops a backup mechanism that some cancer cells use to lengthen telomeres without telomerase.
In cells that lack telomerase, telomeres can be elongated via ALT, a homologous recombination-based process. Negative regulation of ALT involves proteins such as SLX4IP, which dictates telomeric localization in ALT-like castration-resistant prostate cancer cell lines, and DNA polymerase lambda, which plays a role in ALT. Additionally, ALT activity has been observed in various canine sarcomas, underscoring its relevance across species.
Resolution of Telomeric R-loops and G-quadruplexes
In simple terms: This step removes unusual DNA/RNA structures that can otherwise promote telomere lengthening.
Telomeric DNA can form G-quadruplexes and R-loops, which, if unresolved, may facilitate recombination and lengthening. The G-quadruplex resolvase DHX36 (RHAU) unwinds these structures, thereby negatively regulating telomere maintenance. Similarly, the RNA-binding motif protein 14 (RBM14) regulates telomere integrity at the interface of TERRA and telomeric R-loops, acting as a brake on lengthening.
Integration with Genomic Instability and Immune Modulation
In simple terms: This step links telomere length control to broader cellular stress and immune responses.
TERT not only regulates telomere length but also integrates genomic instability and immune modulation, as shown in cancer risk studies. Negative regulation of telomere lengthening via TERT therefore has systemic effects, influencing how cells respond to DNA damage and interact with the immune system.
Key Genes Involved in GO:1904357 negative regulation of telomere maintenance via telomere lengthening
The following genes and proteins are central to the negative regulation of telomere maintenance via telomere lengthening, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TERT | Catalytic subunit of telomerase; its negative regulation prevents telomere elongation | Cancer risk, genomic instability, immune modulation |
| SLX4IP | N-terminus dictates telomeric localization in ALT-like prostate cancer | ALT regulation, prostate cancer |
| POLλ (DNA polymerase lambda) | Plays a role in alternative lengthening of telomeres | ALT mechanism, telomerase-independent lengthening |
| RBM14 | Regulates telomere integrity at TERRA and R-loop interface | Telomere maintenance, R-loop resolution |
| DHX36 (RHAU) | G-quadruplex resolvase; unwinds telomeric G-quadruplexes | Telomere structure, development and disease |
| BEND2 | Fusion genes correlate with poor prognosis in pancreatic neuroendocrine tumors | Cancer prognosis, fusion-driven telomere regulation |
| Satellite cell-related genes | Involved in neuromuscular disorders via satellite cell dysfunction | Muscle regeneration, telomere maintenance in stem cells |
| TERRA | Long non-coding RNA that interacts with telomeres and R-loops | Telomere regulation, R-loop formation |
| Shelterin complex (e.g., TRF1, TRF2) | Protects telomeres and can influence lengthening | Telomere protection, negative regulation |
| ATM/ATR kinases | DNA damage response kinases that can inhibit telomere lengthening | Genomic instability, telomere checkpoint |
| p53 | Tumor suppressor that can repress telomerase | Cancer, telomere shortening |
| RB | Cell cycle regulator linked to telomerase repression | Proliferation control, telomere maintenance |
| MYC | Oncogene that can activate TERT; its negative regulation is indirect | Cancer, telomerase regulation |
| SP1 | Transcription factor regulating TERT promoter | Telomerase expression |
| HSP90 | Chaperone that stabilizes TERT; its inhibition negatively regulates telomerase | Telomerase assembly, cancer therapy |
| DKC1 | Dyskerin, involved in telomerase assembly and stability | Dyskeratosis congenita, telomere maintenance |
| NOP10 | Telomerase complex component | Telomerase biogenesis |
| GAR1 | Telomerase complex component | Telomerase biogenesis |
How Is negative regulation of telomere maintenance via telomere lengthening Regulated?
The negative regulation of telomere maintenance via telomere lengthening is itself subject to multiple layers of control. TERT expression is regulated transcriptionally by factors such as SP1 and MYC, and post-translationally by chaperones like HSP90. Additionally, the DNA damage response kinases ATM and ATR can signal to inhibit telomere lengthening under conditions of genomic stress. In ALT cells, SLX4IP localization and DNA polymerase lambda activity are modulated by recombination machinery. RNA-binding proteins such as RBM14 and DHX36 respond to telomeric R-loops and G-quadruplexes, providing dynamic regulation. These regulatory inputs ensure that telomere lengthening is tightly controlled in response to cellular state and stress.
negative regulation of telomere maintenance via telomere lengthening and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TERT | Cancer risk, genomic instability, immune modulation | CRISPR knockout in cancer cell lines |
| SLX4IP | ALT-like castration-resistant prostate cancer | Knockout in prostate cancer cell lines |
| POLλ | Alternative lengthening of telomeres in cancers | Overexpression in ALT-positive cells |
| RBM14 | Telomere integrity, R-loop regulation | Point mutation knock-in in HEK293T |
| BEND2 | Pancreatic neuroendocrine tumors | Fusion knock-in in pancreatic cell lines |
Cancer
Dysregulation of negative regulation of telomere maintenance via telomere lengthening is a hallmark of cancer. TERT integrates genomic instability and immune modulation, influencing cancer risk. In pancreatic neuroendocrine tumors, recurrent BEND2 fusion genes correlate with poor prognosis, potentially affecting telomere regulation. ALT-positive cancers, such as certain sarcomas and prostate cancers, rely on SLX4IP and DNA polymerase lambda, making them vulnerable to targeted inhibition.
Neuromuscular Disorders
Muscle satellite cell dysfunction, which involves telomere maintenance, contributes to neuromuscular disorders. Negative regulation of telomere lengthening in satellite cells may impair regenerative capacity, linking GO:1904357 to muscle-wasting conditions.
Pancreatic Neuroendocrine Tumors
Recurrent BEND2 fusion genes identified by whole transcriptome sequencing correlate with poor patient prognosis in nonfunctional pancreatic neuroendocrine tumors. These fusions may alter telomere maintenance pathways, highlighting the clinical relevance of negative regulation.
From negative regulation of telomere maintenance via telomere lengthening-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does TERT negative regulation affect telomere length? | TERT knockout via CRISPR in cancer cell lines |
| How does SLX4IP localization impact ALT? | SLX4IP knockout in prostate cancer cells |
| What is the role of DNA polymerase lambda in ALT? | POLλ overexpression in ALT cells |
| How do RBM14 mutations affect telomere integrity? | RBM14 point mutation knock-in |
| Does DHX36 resolve telomeric G-quadruplexes? | DHX36 knockout in HEK293T |
| Can BEND2 fusions drive telomere maintenance? | BEND2 fusion knock-in in pancreatic cells |
How to Study the negative regulation of telomere maintenance via telomere lengthening Process
| Method | What It Measures | Typical Application |
|---|---|---|
| qPCR | Relative telomere length | High-throughput screening |
| TRAP assay | Telomerase activity | Cancer cell lines |
| C-circle assay | ALT activity | ALT-positive tumors |
| FISH | Telomere length and localization | Tissue sections |
| ChIP-seq | Protein binding at telomeres | Shelterin and TERT recruitment |
| CRISPR screen | Gene function in telomere maintenance | Discovery of negative regulators |
| RNA-seq | Transcriptional changes | Pathway analysis |
| Proteomics | Protein interactions | Telomerase complex composition |
Telomere Length Measurement
Telomere length can be measured using quantitative PCR (qPCR), terminal restriction fragment (TRF) analysis, or fluorescence in situ hybridization (FISH). These methods assess the net effect of negative regulation on telomere lengthening.
Telomerase Activity Assays
Telomerase activity is typically measured using the TRAP assay or direct primer extension. These assays quantify the enzymatic activity that is subject to negative regulation.
ALT Detection
ALT activity can be detected by C-circle assay, ALT-associated PML bodies (APBs) imaging, or telomere sister chromatid exchange (T-SCE) analysis. These methods are crucial for studying negative regulation of ALT.
CRISPR Screening and Bioinformatics
Genome-wide CRISPR knockout or activation screens coupled with next-generation sequencing and bioinformatics can identify novel negative regulators of telomere maintenance. Such screens have revealed components like SLX4IP and DNA polymerase lambda.
How CRISPR Can Be Used to Study GO:1904357 negative regulation of telomere maintenance via telomere lengthening
Knockout
CRISPR knockout of candidate negative regulators such as TERT, SLX4IP, or DHX36 can reveal their role in telomere lengthening. For example, TERT knockout leads to telomere shortening and reduced proliferation. SLX4IP knockout impairs ALT and telomeric localization.
Point Mutation
Point mutations can be introduced to dissect specific domains, such as the SLX4IP N-terminus required for telomeric localization, or RBM14 residues critical for R-loop regulation. These models help distinguish loss-of-function from gain-of-function effects.
Knock-in
Knock-in of fusion genes like BEND2 or tagged versions of TERT allows tracking of protein localization and function in telomere maintenance. This approach is valuable for studying disease-associated variants.
Overexpression
Overexpression of negative regulators, such as DNA polymerase lambda or RBM14, can suppress telomere lengthening and induce telomere dysfunction. Conversely, overexpression of TERT can overcome negative regulation and elongate telomeres.
How EDITGENE Supports negative regulation of telomere maintenance via telomere lengthening Research
Researchers studying negative regulation of telomere maintenance via telomere lengthening-related genes often need to determine whether a candidate gene is causally involved in telomere length control, ALT suppression, or telomerase inhibition. EDITGENE provides a comprehensive suite of CRISPR services to enable such functional studies with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of telomere maintenance via telomere lengthening research.
Frequently Asked Questions About negative regulation of telomere maintenance via telomere lengthening
What is GO:1904357?
GO:1904357 is a Gene Ontology biological process term defined as any process that stops, prevents, or reduces the frequency, rate, or extent of telomere maintenance via telomere lengthening.
What genes are involved in negative regulation of telomere maintenance via telomere lengthening?
Key genes include TERT, SLX4IP, DNA polymerase lambda, RBM14, and DHX36, among others.
How does TERT negatively regulate telomere lengthening?
TERT is the catalytic subunit of telomerase; its downregulation or inhibition prevents telomere elongation. Negative regulation occurs at transcriptional and post-translational levels.
What is alternative lengthening of telomeres (ALT)?
ALT is a telomerase-independent mechanism that elongates telomeres via homologous recombination. It is negatively regulated by factors such as SLX4IP and DNA polymerase lambda.
Which diseases are linked to defective negative regulation of telomere lengthening?
Cancer, neuromuscular disorders, and pancreatic neuroendocrine tumors have been associated with dysregulation of this process.
How can I study negative regulation of telomere maintenance in the lab?
Common methods include telomere length measurement (qPCR, TRF), telomerase activity assays (TRAP), ALT detection (C-circle), and CRISPR screens.
What is the role of DHX36 in telomere regulation?
DHX36 (RHAU) is a G-quadruplex resolvase that unwinds telomeric G-quadruplexes, thereby negatively regulating telomere lengthening.
How does RBM14 affect telomeres?
RBM14 regulates telomere integrity at the interface of TERRA and telomeric R-loops, acting as a negative regulator.
Can CRISPR be used to study GO:1904357?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect the mechanisms of negative regulation.
What experimental models are suitable for studying negative regulation of telomere lengthening?
Cancer cell lines, ALT-positive cells, and animal models with specific gene knockouts or knock-ins are commonly used.
Conclusion
GO:1904357, negative regulation of telomere maintenance via telomere lengthening, is a vital biological process that safeguards against unchecked telomere elongation. Its dysregulation contributes to cancer, neuromuscular disorders, and other diseases. Through the integration of QuickGO data and verified literature, this article highlights the key genes, mechanisms, and experimental approaches. CRISPR-based models from EDITGENE can accelerate discoveries in this field, enabling precise manipulation of telomere regulatory networks.
References
- 1. Ganassi M et al.. 2022. Involvement of muscle satellite cell dysfunction in neuromuscular disorders: Expanding the portfolio of satellite cell-opathies.. Eur J Transl Myol 32(1) PMID: 35302338
- 2. Wood-Trageser MA et al.. 2025. Recurrent BEND2 Fusion Genes Identified by Whole Transcriptome Sequencing of Nonfunctional Pancreatic Neuroendocrine Tumors Correlate With Poor Patient Prognosis.. Mod Pathol 38(10):100863 PMID: 40784487
- 3. Zhao J et al.. 2025. TERT links telomere length to cancer risk by integrating genomic instability and immune modulation.. Discov Oncol 16(1):1788 PMID: 41026280
- 4. Kreilmeier T et al.. 2017. Alternative lengthening of telomeres does exist in various canine sarcomas.. Mol Carcinog 56(3):923-935 PMID: 27585244
- 5. Yang C et al.. 2022. To unwind the biological knots: The DNA/RNA G-quadruplex resolvase RHAU (DHX36) in development and disease.. Animal Model Exp Med 5(6):542-549 PMID: 35789129
- 6. Mangosh TL et al.. 2021. SLX4IP N-terminus dictates telomeric localization in ALT-like castration-resistant prostate cancer cell lines.. Prostate 81(15):1235-1251 PMID: 34492133
- 7. Wang Y et al.. 2023. The RNA-binding motif protein 14 regulates telomere integrity at the interface of TERRA and telomeric R-loops.. Nucleic Acids Res 51(22):12242-12260 PMID: 37930826
- 8. Mentegari E et al.. 2021. A Role for Human DNA Polymerase λ in Alternative Lengthening of Telomeres.. Int J Mol Sci 22(5) PMID: 33673424
